Ashvattha Therapeutics Secures $50M, Unveils Promising Ophthalmology Trial Results
Ashvattha Therapeutics secured up to $50 million in extended Series B funding, led by Tribe Capital with continued support...
Pioneering the First Lab and Theranostic Platform: A Conversation with NuView CEO, Paul Crowe
NuView Life Sciences is transforming cancer diagnostics and treatment with its pioneering NV-VPAC1™ platform. This first-of-its-kind technology integrates in...
Dynamic Consent: A New GDPR Standard for Clinical Trials
In an era where data is the cornerstone of innovation, the concept of dynamic consent is emerging as a...
EMA Discusses European Clinical Trial Decline at DTRA
At the 2024 Decentralized Trials & Research Alliance (DTRA) Annual Meeting, Dr. Amir Kalali of the DTRA and Dr....
Brio-II Phase 3 Study Shows Positive Topline Data for Brimochol™ PF in Presbyopia Treatment
Tenpoint Therapeutics announced positive topline results from its Phase 3 BRIO-II trial of BRIMOCHOL™ PF, a carbachol/brimonidine tartrate eye...
Rapport Therapeutics Announces Promising Phase 1 Data for CNS Disorders
Rapport Therapeutics (Nasdaq: RAPP) announced positive Phase 1 results for RAP-219, a drug candidate for central nervous system disorders....
MRNA Cancer Vaccine Clinical Trials & Research
Over 60 mRNA cancer vaccine candidates are currently in clinical trials, with two reaching Phase III. BioNTech‘s BNT111, a...
Alkeus GLY2 prevents Stargardt Progression in Phase 3 Study
Alkeus Pharmaceuticals announced positive interim data from its TEASE-3 Stargardt disease study. Two additional participants who completed 24 months...
IO Biotech’s Cancer Vaccine Trial Enrolls Patients with Melanoma and Head/Neck Cancer
IO Biotech has completed enrollment in its Phase 2 basket trial, IOB-032/PN-E40, ahead of schedule. The trial evaluates the...
Acumen Pharmaceutics Alzheimer’s Prevention Study in Journal
Acumen Pharmaceuticals announced positive Phase 1 clinical trial results for sabirnetug (ACU193), a potential Alzheimer’s diseaseAlzheimer’s disease treatment targeting...